Description
TELMEJEY-H is a fixed-dose combination antihypertensive formulation by Ellanjey that combines Telmisartan (40 mg) – a potent Angiotensin II Receptor Blocker (ARB) – with Hydrochlorothiazide (12.5 mg) – a well-established thiazide diuretic. This combination is indicated for the treatment of essential hypertension (high blood pressure) in patients whose blood pressure is not adequately controlled on monotherapy with either agent alone.
Key Benefits:
-
Dual Mechanism of Action – ARB (blocks angiotensin II) + Thiazide diuretic (reduces fluid volume).
-
Enhanced BP Reduction – Combination lowers BP more effectively than either drug alone (additive effect).
-
24-Hour Blood Pressure Control – Telmisartan’s long half-life provides consistent coverage.
-
Counteracts Diuretic Side Effects – ARB reduces hypokalemia (low potassium) caused by HCTZ.
-
Cardiovascular Protection – Telmisartan provides proven CV event reduction (ONTARGET study).
-
Metabolically Neutral – ARB improves insulin sensitivity; HCTZ may raise glucose (monitored).
-
No Cough – ARBs do not cause cough (unlike ACE inhibitors).
FAQs:
1. Why is Hydrochlorothiazide added to Telmisartan?
HCTZ reduces blood pressure through a different mechanism (reducing fluid volume). Together, they provide additive BP lowering and allow lower doses of each drug, reducing side effects.
2. Does Telmejey-H cause low potassium (hypokalemia)?
HCTZ can cause potassium loss, but telmisartan tends to increase potassium. At the 12.5 mg HCTZ dose, these effects often balance, but your doctor should monitor your potassium levels.
3. Can I take Telmejey-H at bedtime?
Morning dosing is recommended because HCTZ increases urination (taking at night may disrupt sleep). Telmisartan provides 24-hour coverage regardless of morning dosing.
4. Is Telmejey-H safe for patients with diabetes?
Yes, but with monitoring. HCTZ may slightly raise blood glucose, while telmisartan improves insulin sensitivity. Monitor blood glucose more frequently, especially when starting.
Call us 
Contact Us
